Kevin Ali was appointed as the CEO of Organon & Co. on August 7, 2025.
1 report, 1 independent
Updated Aug 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Kevin Ali was appointed as the CEO of Organon & Co. on August 7, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Organon & Co.
pharmaceutical company
Nothing else this week.
Coverage
Newest first; wire copies grouped- Insider MonkeyOrganon & Co. (OGN) Slashes 13.13% on Disappointing Earnings We recently published 10 Big Names Bleed Double Digits. Organon & Co. (NYSE:OGN) is one of the worst-performing stocks on Tuesday. Organon